Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,265 | -31,285 | -22,569 | -11,101 | -42,931 |
| Depreciation Amortization | 7,012 | 5,272 | 3,555 | 1,787 | 8,156 |
| Accounts receivable | -531 | -4,139 | 1,085 | 904 | -1,811 |
| Other Working Capital | 334 | -1,510 | 1,433 | -739 | -21,669 |
| Other Operating Activity | 5,179 | 7,613 | 1,326 | 547 | 9,606 |
| Operating Cash Flow | $-23,271 | $-24,049 | $-15,170 | $-8,602 | $-48,649 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -259 | -173 | -125 | -74 | -3,230 |
| Purchase Sale Intangibles | -144 | -126 | -107 | -63 | -210 |
| Other Investing Activity | -144 | -126 | -107 | -63 | -210 |
| Investing Cash Flow | $-403 | $-299 | $-232 | $-137 | $-3,440 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | N/A | N/A |
| Debt Repayment | -21 | -16 | -12 | -7 | -51 |
| Common Stock Issued | 7,817 | 5,497 | 313 | 313 | 56,275 |
| Other Financing Activity | -1,379 | -773 | -415 | -209 | -4,174 |
| Financing Cash Flow | $16,417 | $14,708 | $9,886 | $97 | $52,050 |
| Beginning Cash Position | 26,332 | 26,332 | 26,332 | 26,332 | 26,371 |
| End Cash Position | 19,075 | 16,692 | 20,816 | 17,690 | 26,332 |
| Net Cash Flow | $-7,257 | $-9,640 | $-5,516 | $-8,642 | $-39 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,271 | -24,049 | -15,170 | -8,602 | -48,649 |
| Capital Expenditure | -259 | -173 | -125 | -74 | -3,230 |
| Free Cash Flow | -23,530 | -24,222 | -15,295 | -8,676 | -51,879 |